IL-8 is also released from the tumor microenvironment into the systemic circulation, and serum IL-8 levels are increased in patients with a variety of cancers, including pancreatic, colon, renal, prostate, liver, esophageal, and lung cancers [18,19,57,58,59]. This evidence concerns the gene CXCL8 and lung carcinoma.